Journal
VACCINE
Volume 29, Issue 6, Pages 1319-1323Publisher
ELSEVIER SCI LTD
DOI: 10.1016/j.vaccine.2010.11.051
Keywords
Vaccine; Thrombocytopenia; Postmarketing safety; Adverse event
Categories
Ask authors/readers for more resources
We reviewed thrombocytopenia (TP) reports to the US Vaccine Adverse Event Reporting System (VAERS). We examined TP patterns for differences in single versus multiple immunization reports, presence of a live viral vaccine, seriousness, age, and interval to symptom onset. We found 1510 reports of possible TP and after exclusions evaluated 1440 for possible causes. Most (1078; 75%) met the regulatory definition of a serious adverse event. TP was reported after inactivated and live viral vaccines. Platelet counts <10 x 10(9)/L were reported. Identified vaccines could be prioritized for hypothesis-testing studies. Published by Elsevier Ltd.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available